Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000 bottles, Rx Only, Manufactured for Acc...

FDA Recall #D-0394-2025 — Class II — April 10, 2025

Recall #D-0394-2025 Date: April 10, 2025 Classification: Class II Status: Ongoing

Product Description

Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-447-17

Reason for Recall

Subpotent

Recalling Firm

ACCORD HEALTHCARE, INC. — Raleigh, NC

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

4,888 Bottles

Distribution

Nationwide US.

Code Information

Lot # D2300323, Exp Date: 01/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated